Keywords: uk, antisoma, buy, xanthus, usa, raises, additional
UK's Antisoma to buy Xanthus of the USA and raises additional L20.9M
Article | 26 May 2008
London, UK-headquartered cancer drug developer Antisoma says that it has entered into an agreement to acquire privately-held US oncology company ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
